Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database ; volume:20 ; number:1 ; day:16 ; month:6 ; year:2020 ; pages:1-13 ; date:12.2020
BMC psychiatry ; 20, Heft 1 (16.6.2020), 1-13, 12.2020
- Urheber
-
Revet, Alexis
Montastruc, François
Roussin, Anne
Raynaud, Jean-Philippe
Lapeyre-Mestre, Maryse
Nguyen, Thi Thu Ha
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12888-020-02711-z
- URN
-
urn:nbn:de:101:1-2020081321385909115498
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Revet, Alexis
- Montastruc, François
- Roussin, Anne
- Raynaud, Jean-Philippe
- Lapeyre-Mestre, Maryse
- Nguyen, Thi Thu Ha
- SpringerLink (Online service)
Ähnliche Objekte (12)
A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
Post-marketing safety concerns with rimegepant based on a pharmacovigilance study
Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database
Antidepressants
Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database
Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database
Antidepressants and age
Antidepressants and Age
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Coadministration of tizanidine and ciprofloxacin: a retrospective analysis of the WHO pharmacovigilance database
Pharmacovigilance in oncology
A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
Post-marketing safety concerns with rimegepant based on a pharmacovigilance study
Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database
Antidepressants
Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database
Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database
Antidepressants and age
Antidepressants and Age
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Coadministration of tizanidine and ciprofloxacin: a retrospective analysis of the WHO pharmacovigilance database
Pharmacovigilance in oncology
A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
Post-marketing safety concerns with rimegepant based on a pharmacovigilance study
Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database
Antidepressants
Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database
Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database
Antidepressants and age
Antidepressants and Age
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Coadministration of tizanidine and ciprofloxacin: a retrospective analysis of the WHO pharmacovigilance database